INS and metabolic syndrome: MetS is characterized by hypertension, dyslipidemia, glucose intolerance, as well as central obesity; visceral obesity may be responsible for insulin resistance, impaired lipolysis and increased free fatty acid (FFA) release; FFAs inhibit insulin effects and reduce glycogen synthesis, thus stimulating glucose production and lipogenesis [2].